In case anyone missed this presentation.
https://www.aats.org/resources/lb4-prospective-single-center-randomized-control-trial-to-evaluate-the-safety-and-feasibility-of-a-novel-allogenic-mesenchymal-precursor-cell-therapy-in-patients-with-hypoplastic-left-heart-syndrome-2
Doctors are impatient for this stem cell therapy for their patients… not my words but
rather the words from a doctor during question time.
Well done to Boston’s Children’s Hospital for trailblazing this new treatment… again a doctor’s words, not mine.
Bring on MSB’s Phase 3 trial
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-223
-
- There are more pages in this discussion • 158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |